GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis

Journal of Hepatology

Volumn 27, Issue 3, 1997, Pages 464-469

  Kanda, Tatsuo ^a   Yokosuka, Osamu ^a   Imazeki, Fumio ^a   Tagawa, Masami ^a   Ehata, Toshiki ^a   Saisho, Hiromitsu ^a   Omata, Masao ^b  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

GBV C; Hepatocellular carcinoma; Japan

Indexed keywords

HELICASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BASE PAIRING; CHRONIC LIVER DISEASE; FEMALE; HEPATITIS NON A NON B; HUMAN; INFECTION RISK; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA VIRUS; VIRUS DETECTION; VIRUS GENOME;

EID: 0030822202     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80349-2     Document Type: Article

References (27)

1. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology. 22:1995;1027-1033.
2. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer. 67:1991;429-433.
3. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 47:1987;4967-4972.
4. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res. 51:1991;2842-2847.
5. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chornic hepatitis B and C: a prospective study of 251 patients. Hepatology. 21:1995;650-655.
6. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med. 1:1995;564-569.
7. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol. 48:1996;60-67.
8. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
9. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med. 334:1996;1485-1490.
10. Nakatsuji Y, Shih JW-K, Tanaka E, Kiyosawa K, Wages J Jr, Kim JP, et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepatitis. 3:1996;307-316.
11. Kinoshita T, Miyake K, Nakao H, Tanaka T, Tsuda F, Okamoto H, et al. Molecular investigation of GB virus C infection in hemophiliacs in Japan. J Infect Dis. 175:1997;454-457.
12. Orito E, Mizokami M, Nakano T, Wu R-R, Cao K, Ohba K, et al. GB virus C/ hepatitis G virus infection among Japanese patients with chronic liver diseases and blood donors. Virus Res. 46:1996;89-93.
13. Yokosuka O, Kato N, Hosoda K, Ito Y, Imazeki F, Ohto M, et al. Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA. Gut. 37:1995;721-726.
14. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology. 18:1993;16-20.
15. Kato N, Yokosuka O, Omata M, Hosoda K, Ohto M. Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J Clin Invest. 86:1990;1764-1767.
16. Hosoda K., Omata M, Yokosuka O, Kato N, Ohto M. Nucleotide sequences of 5-1-1 of hepatitis C virus in patients with chronic liver disease. Gastroenterology. 102:1992;1039-1043.
17. Egawa K, Yukawa T, Arakawa S, Nakao H, Inoue T, Tanaka T, et al. Infection with GB virus C in leprous patients in Japan. J Med Virol. 49:1996;110-114.
18. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science. 244:1989;362-364.
19. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science. 244:1989;359-361.
20. Papatheodoridis GV, Felladetsima I, Koutelou M, Katsoulidou A, Hatzakis A, Tassopoulos NC. Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease. J Hepatol. 20:1994;311.
21. Alter HJ. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology. 15:1992;350-353.
22. Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet. 335:1990;1-3.
23. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol. 1993;240-243.
24. Bukh J, Miller RH, Kew MC, Purcell RH. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci USA. 90:1993;1848-1851.
25. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Consensus oligonucleotide primers for the detection of GB virus C in human cryptogenic hepatitis. J Virol Methods. 56:1996;119-121.
26. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med. 334:1996;195-196.
27. Takano S, Nakamura K, Kawai S, Yokosuka O, Satomura Y, Omata M. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis. Hepatology. 23:1996;708-712.